Lareau, C A
White, B C
Oberg, A L
Kennedy, R B
Poland, G A
McKinney, B A
Article History
Received: 5 November 2015
Revised: 6 December 2015
Accepted: 4 January 2016
First Online: 7 April 2016
Competing interests
: Dr Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr Poland offers consultative advice on vaccine development to Merck & Co. Inc., CSL Biotherapies, Avianax, Dynavax, Novartis Vaccines and Therapeutics, Emergent Biosolutions, Adjuvance and Microdermis. Dr Poland holds two patents related to vaccinia and measles peptide research. These research activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies.
Free to read: This content has been made available to all.